护理学报 ›› 2021, Vol. 28 ›› Issue (6): 17-21.doi: 10.16460/j.issn1008-9969.2021.06.017
急性缺血性脑卒中患者静脉溶栓后出血转化预测模型的研究进展
周田田1, 黄萍1, 邹圣强2
- 1.南京大学医学院附属鼓楼医院 急诊科,江苏 南京210008;
2.江苏大学附属镇江三院 重症医学科,江苏 镇江 212005
摘要： 目的 总结目前国内外关于急性缺血性脑卒中患者静脉溶栓后出血转化的预测模型,为今后开展相关研究提供参考依据。方法 计算机检索PubMed、Web of Science、Sciencedirect、Scopus、中国知网、万方等数据库中关于急性缺血性脑卒中患者静脉溶栓后出血转化预测模型的文献,并进行分析与汇总,检索时限为建库至2020年6月。结果 最终检索并总结9个预测模型,其中国外有iScore模型、SEDAN模型、THRIVE模型、SITS模型、STARTING-SICH模型、SICH SCORE模型共6种,国内有THRIVE-c模型、Xu团队的模型、常红团队的模型共3种。结论 国内外目前关于急性脑卒中患者溶栓后发生出血转化的预测模型各有优缺点,国内应在学习国外风险预测模型研究的基础上,进一步探索我国急性脑卒中患者溶栓后发生出血的风险因素并构建模型,从而为高危人群筛查和早期干预提供科学依据。
中图分类号:
- R473.74
| [1] Benjamin EJ, Blaha MJ, Chiuve SE, et al.Heart Disease and Stroke Statistics-2017 Update:A Report from the American Heart Association[J].Circulation,2017, 135(10):e146-e603. DOI:10.1161/CIR.0000000000000485. [2] 中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组.中国急性缺血性脑卒中诊治指南2018[J].中华神经科杂志, 2018,51(9):666-682. DOI:10.3760/cma.j.issn.1006-7876.2018.09.004. [3] Wardlaw JM, Murray V, Berge E, et al.Recombinant Tissue Plasminogen Activator for Acute Ischaemic Stroke:An Updated Systematic Review and Meta-analysis[J].Lancet,2012,379(9834):2364-2372. DOI:10.1016/S0140-6736(12)60738-7. [4] Chen YW, Sung SF,Chen CH, et al.Intravenous Thrombolysis Administration 3-4.5h after Acute Ischemic Stroke: A Retrospective, Multicenter Study[J].Front Neurol,2019,10:1038. DOI:10.3389/fneur.2019.01038. [5] Powers WJ, Rabinstein AA, Ackerson T, et al.Guidelines forthe Early Management of Patients with Acute Ischemic Stroke:2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke:A Guideline for Healthcare Professionals from the American Heart Association/American Stroke Association[J].Stroke, 2019,50(12):e344-e418. DOI:10.1161/STR.0000000000000211. [6] Romano JG,Smith EE,Liang L,et al.Outcomes in Mild Acute Ischemic Stroke Treated with Intravenous Thrombolysis:A Retrospective Analysis of the Get with the Guidelines-stroke Registry[J].JAMA Neurol, 2015, 72(4):423-431. DOI:10.1001/jamaneurol.2014.4354. [7] Saposnik G, Kapral MK, Liu Y, et al.iScore:A Risk Score to Predict Death Early after Hospitalization for an Acute Ischemic Stroke[J].Circulation, 2011, 123(7):739-749. DOI: 10.1161/CIRCULATIONAHA.110.983353. [8] Saposnik G, Raptis S, Kapral MK, et al.The iScore Predicts Poor Functional Outcomes Early after Hospitalization for an Acute Ischemic Stroke[J].Stroke, 2011, 42(12):3421-3428. DOI:10.1161/STROKEAHA.111.623116. [9] Saposnik G, Demchuk A, Tu JV,et al.The iScore Predicts Efficacy and Risk of Bleeding in the National Institute of Neurological Disorders and Stroke Tissue Plasminogen Activator Stroke Trial[J].J Stroke Cerebrovasc Dis,2013,22(6):876-882. DOI:10.1016/j.jstrokecerebrovasdis.2012.09.001. [10] Park TH, Park SS,Ko Y,et al.The iScore Predicts Clinical Response to Tissue Plasminogen Activator in Korean Stroke Patients[J].J Stroke Cerebrovasc Dis, 2014,23(2):367-373. DOI:10.1016/j.jstrokecerebrovasdis.2013.05.025. [11] Strbian D,Engelter S,Michel P,et al.Symptomatic Intracranial Hemorrhage after Stroke Thrombolysis: The SEDAN Score[J].Ann Neurol, 2012,71(5):634-641. DOI:10.1002/ana.23546. [12] Al-Khaled M, Langner B, Brüning T.Predicting Risk of Symptomatic Intracerebral Hemorrhage and Mortality after Treatment with Recombinant Tissue-plasminogen Activator Using SEDAN Score[J].Acta Neurol Scand, 2016,133(4):239-244. DOI:10.1111/ane.12447. [13] Flint AC, Cullen SP, Faigeles BS, et al.Predicting Long-Term Outcome after Endovascular Stroke Treatment: The Totaled Health Risks in Vascular Events Score[J].Am J Neuroradiol,2010,31(7):1192-1196. DOI:10.3174/ajnr.A2050.[14] Flint AC, Kamel H, Rao VA, et al.Validation of the Totaled Health Risks in Vascular Events (THRIVE) Score for Outcome Prediction in Endovascular Stroke Treatment[J].Int J Stroke,2014, 9(1):32-39. DOI10.1111/j.1747-4949.2012.00872.x. [15] Flint AC, Faigeles BS, Cullen SP,et al.THRIVE Score Predicts Ischemic Stroke Outcomes and Thrombolytic Hemorrhage Risk in VISTA[J].Stroke,2013,44(12):3365-3369. DOI:10.1161/STROKEAHA.113.002794. [16] Flint AC, Gupta R, Smith WS, et al.The THRIVE Score Predicts Symptomatic Intracerebral Hemorrhage after Intravenous tPA Administration in SITS-MOST[J].Int J Stroke,2014,9(6):705-710. DOI:10.1111/ijs.12335. [17] Mazya M, Egido JA, Ford GA, et al.Predicting the Risk of Symptomatic Intracerebral Hemorrhage in Ischemic Stroke Treated with Intravenous Alteplase: Safe Implementation of Treatments in Stroke(SITS) Symptomatic Intracerebral Hemorrhage Risk Score[J].Stroke,2012,43(6):1524-1531. DOI: 10.1161/STROKEAHA.111.644815. [18] Nisar T, Hanumanthu R, Khandelwal P.Symptomatic Intracerebral Hemorrhage after Intravenous Thrombolysis: Predictive Factors and Validation of Prediction Models[J].J Stroke Cerebrovasc Dis,2019,28(11):104360. DOI:10.1016/j.jstrokecerebrovasdis.2019.104360. [19] Cappellari M,Turcato G, Forlivesi S,et al.STARTING-SICH Nomogram to Predict Symptomatic Intracerebral Hemorrhage After Intravenous Thrombolysis for Stroke[J].Stroke,2018,49(2):397-404. DOI:10.1161/STROKEAHA.117.018427. [20] Diedler J, Ahmed N, Sykora M, et al.Safety of Intravenous Thrombolysis for Acute Ischemic Stroke in Patients Receiving Antiplatelet Therapy at Stroke Onset[J].Stroke,2010,41(2):288-294. DOI:10.1161/STROKEAHA.109.559724. [21] Cucchiara B, Kasner SE, Tanne D, et al.Factors Associated with Intracerebral Hemorrhage after Thrombolytic Therapy for Ischemic Stroke: Pooled Analysis of Placebo Data from the Stroke-Acute Ischemic NXY Treatment (SAINT) I and SAINT II Trials[J].Stroke, 2009,40(9):3067-3072. DOI:10.1161/STROKEAHA.109.554386. [22] Ruecker M, Matosevic B, Willeit P, et al.Subtherapeutic Warfarin Therapy Entails an Increased Bleeding Risk after Stroke Thrombolysis[J].Neurology,2012,79(1):31-38. DOI: 10.1212/WNL.0b013e31825dcdf0. [23] Miedema I, Luijckx GJ, De Keyser J, et al.Thrombolytic Therapy for Ischaemic Stroke in Patients Using Warfarin: A Systematic Review and Meta-analysis[J].J Neurol Neurosurg Psychiatry,2012, 83(5):537-540. DOI:10.1136/jnnp-2011-301794. [24] Xian Y, Liang L, Smith EE, et al.Risks of Intracranial Hemorrhage among Patients with Acute Ischemic Stroke Receiving Warfarin and Treated with IntravenousTissue Plasminogen Activator[J].JAMA,2012,307(24):2600-2608. DOI:10.1001/jama.2012.6756. [25] Lokeskrawee T, Muengtaweepongsa S, Patumanond J, et al.Prediction of Symptomatic Intracranial Hemorrhage after Intravenous Thrombolysis in Acute Ischemic Stroke: The Symptomatic Intracranial Hemorrhage Score[J].J Stroke Cerebrovasc Dis,2017, 26(11):2622-2629. DOI:10.1016/j.jstrokecerebrovasdis.2017.06.030. [26] Pan Y, Peng Y, Chen W,et al.THRIVE-c Score Predicts Clinical Outcomes in Chinese Patients after Thrombolysis[J].Brain Behav,2018,8(2):e00927. DOI:10.1002/brb3.927. [27] Xu X, Li C, Wan T, et al.Risk Factors for Hemorrhagic Transformation Following Intravenous Thrombolysis in Acute Cerebral Infarction:A Retrospective Single Center Study[J].World Neurosurgery, 2017,101:155-160. DOI:10.1016/j.wneu.2017.01.091. [28] 常红,赵洁,王晓娟,等.急性缺血性脑卒中患者静脉溶栓后出血预警模型的构建[J].中华护理杂志, 2019, 54(11):1648-1652. DOI:10.3761/j.issn.0254-1769.2019.11.010. [29] Wang R, Zeng J, Wang F,et al.Risk Factors of Hemorrhagic Transformation after Intravenous Thrombolysis with rt-PA in Acute Cerebral Infarction[J].QJM, 2019,112(5):323-326. DOI:10.1093/qjmed/hcy292. |
| [1] | 郑小静, 严红虹, 李慧景, 陈思涓, 陈秀梅. 肝细胞癌伴低血糖症风险预测模型的构建与验证[J]. 护理学报, 2025, 32(4): 53-58. |
| [2] | 伍丽华, 吴心雨, 赖湘瑜, 邓宝贵, 黄泽青, 赵耀, 廖源, 沈彩萍, 李瑜. 人工关节置换术后患者深静脉血栓风险预测模型的系统评价[J]. 护理学报, 2025, 32(3): 12-16. |
| [3] | 李雪, 廖常菊, 张健, 丁娟, 陈晓丽, 胡玉庭. 三级甲等医院ICU护士睡眠障碍的风险预测模型构建及验证[J]. 护理学报, 2025, 32(2): 63-69. |
| [4] | 周越, 张杰, 潘宇帆, 戴雨, 孙羽健, 肖益, 余雨枫. 机械通气患者衰弱风险预测模型的系统评价[J]. 护理学报, 2024, 31(6): 56-61. |
| [5] | 邢春凤, 李国新, 张广清, 刘雅鑫, 孙晓伟. 产妇产褥期乳房胀痛危险因素分析及风险预测模型构建[J]. 护理学报, 2024, 31(3): 6-11. |
| [6] | 王丽云, 张明慧, 张新月, 沙凯辉. 产后压力性尿失禁风险预测模型的系统评价[J]. 护理学报, 2024, 31(3): 57-62. |
| [7] | 赵国瑞, 刘高明, 张凤, 周颖. 宫颈癌患者术后下肢淋巴水肿风险预测模型的构建及验证[J]. 护理学报, 2024, 31(24): 7-12. |
| [8] | 王月, 刘国庆, 牛聪影, 张振伟, 孙建, 褚友艾, 秦寒枝. 髋部骨折患者术后30天死亡风险预测模型的范围综述[J]. 护理学报, 2024, 31(24): 51-56. |
| [9] | 杨丽娜, 黄蓉, 姚梅琦, 王竹青, 徐怡婷, 谢佩敏. 产后母乳喂养行为中断风险预测模型的系统评价[J]. 护理学报, 2024, 31(23): 59-65. |
| [10] | 章明阳, 刘京辉, 金雁, 徐文琪, 李斌飞, 黄珊, 杜李百合, 侯亚甜, 李小寒. 围手术期低体温风险预测模型的系统评价[J]. 护理学报, 2024, 31(22): 54-60. |
| [11] | 姜宁宁. 连续性肾脏替代治疗患者低体温发生风险列线图预测模型构建与验证[J]. 护理学报, 2024, 31(19): 65-72. |
| [12] | 杨蓓, 叶红芳, 相卢伟, 路诗雨. 中老年2型糖尿病患者轻度认知障碍风险预测模型的构建与验证[J]. 护理学报, 2024, 31(13): 18-23. |
| [13] | . 轻度认知障碍向阿尔兹海默病进展风险预测模型的系统评价[J]. 护理学报, 2024, 31(12): 47-53. |
| [14] | 欧阳蝶, 许豆豆, 孙燕荣, 陈莹, 吕安康, 吴蓓雯. 基于生活方式相关指标的非肥胖人群非酒精性脂肪肝预测模型的构建[J]. 护理学报, 2024, 31(10): 1-7. |
| [15] | 邬馨益, 徐林燕, 陈卓琦, 朱徐乐, 赵磊. 老年人运动认知功能减退综合征风险预测模型的构建与验证[J]. 护理学报, 2024, 31(10): 73-78. |
|
||